1. Home
  2. ADVM vs RFIL Comparison

ADVM vs RFIL Comparison

Compare ADVM & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • RFIL
  • Stock Information
  • Founded
  • ADVM 2006
  • RFIL 1979
  • Country
  • ADVM United States
  • RFIL United States
  • Employees
  • ADVM N/A
  • RFIL N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • RFIL Electrical Products
  • Sector
  • ADVM Health Care
  • RFIL Technology
  • Exchange
  • ADVM Nasdaq
  • RFIL Nasdaq
  • Market Cap
  • ADVM 47.4M
  • RFIL 44.7M
  • IPO Year
  • ADVM 2014
  • RFIL N/A
  • Fundamental
  • Price
  • ADVM $2.25
  • RFIL $4.86
  • Analyst Decision
  • ADVM Strong Buy
  • RFIL Strong Buy
  • Analyst Count
  • ADVM 5
  • RFIL 1
  • Target Price
  • ADVM $26.40
  • RFIL $4.50
  • AVG Volume (30 Days)
  • ADVM 186.4K
  • RFIL 49.0K
  • Earning Date
  • ADVM 08-11-2025
  • RFIL 06-16-2025
  • Dividend Yield
  • ADVM N/A
  • RFIL N/A
  • EPS Growth
  • ADVM N/A
  • RFIL N/A
  • EPS
  • ADVM N/A
  • RFIL N/A
  • Revenue
  • ADVM $1,000,000.00
  • RFIL $73,399,000.00
  • Revenue This Year
  • ADVM N/A
  • RFIL $16.16
  • Revenue Next Year
  • ADVM $18.82
  • RFIL $5.75
  • P/E Ratio
  • ADVM N/A
  • RFIL N/A
  • Revenue Growth
  • ADVM N/A
  • RFIL 20.14
  • 52 Week Low
  • ADVM $1.78
  • RFIL $3.22
  • 52 Week High
  • ADVM $10.14
  • RFIL $5.77
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 40.11
  • RFIL 67.99
  • Support Level
  • ADVM $2.21
  • RFIL $4.08
  • Resistance Level
  • ADVM $3.10
  • RFIL $4.32
  • Average True Range (ATR)
  • ADVM 0.22
  • RFIL 0.28
  • MACD
  • ADVM -0.00
  • RFIL 0.08
  • Stochastic Oscillator
  • ADVM 4.49
  • RFIL 79.28

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About RFIL RF Industries Ltd.

RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.

Share on Social Networks: